Megarounds make a comeback as biotech starts to reboundnews2025-10-17T14:00:14+00:00October 17th, 2025|Endpoints News|
Boehringer Ingelheim names global obesity leader; Calico taps AbbVie vet for discovery rolenews2025-10-17T11:00:38+00:00October 17th, 2025|Endpoints News|
Roche inks $80M upfront deal for Hansoh’s cancer ADCnews2025-10-17T09:41:33+00:00October 17th, 2025|Endpoints News|
Trump announces ‘most favored nation’ deal with EMD Serono to boost IVF accessnews2025-10-16T21:42:18+00:00October 16th, 2025|Endpoints News|
I-Mab remakes itself, with plans for Hong Kong listing, retinal R&D, and a new namenews2025-10-16T20:05:59+00:00October 16th, 2025|Endpoints News|
British startup Genomics launches business to help drug developersnews2025-10-16T19:34:15+00:00October 16th, 2025|Endpoints News|
Pregene lands up to $1.52B deal with Kite for in vivo therapiesnews2025-10-16T19:25:26+00:00October 16th, 2025|Endpoints News|
Pfizer CEO says US must compete better against China, not block itnews2025-10-16T19:06:09+00:00October 16th, 2025|Endpoints News|
California to offer its own, cheaper version of insulin pensnews2025-10-16T17:05:45+00:00October 16th, 2025|Endpoints News|
FDA tells Supreme Court to pass on Vanda’s fast-track status fightnews2025-10-16T16:47:56+00:00October 16th, 2025|Endpoints News|
